The purpose of this grant application is to request core support as an NCI-designated clinical cancer center for the Institute for Cancer Research and Care / San Antonio. The Institute for Cancer Research and Care (ICRC) is a collaborative venture of the Cancer Therapy and Research Foundation of South Texas (CTRF) and the University of Texas Health Science Center at San Antonio (UTHSCSA). The Institute was established to provide experienced leadership and a strong focus for all cancer-related research conducted in or through these organizations. This cancer center has been under development since the mid-1980's and was formally recognized by the CTRF and the UTHSCSA in the spring of 1990. The mission of the cancer center is to provide the organizational framework and the resources required to promote interdisciplinary research in defined clinical and basic science areas related to cancer and to foster the application of the results of that research in the community setting, particularly in the community served by the affiliate members of the cancer center. There are five major research programs in the Institute for Cancer Research and Care. These programs represent coordinated efforts among a number of multidisciplinary investigators in the areas of Breast Cancer Research, Clinical Investigations, Drug Development, Growth Factor Research, and Molecular Genetics. To support and enhance the development of these programs, the cancer center has established nine shared core facilities, including biostatistics, pharmacology, pathology, flow cytometry, research protocol administration, molecular biology, laboratory animal resources, tissue culture, and maintenance of shared equipment. Both the CTRF and the UTHSCSA have committed substantial resources to the ICRC for the support of the center's programs as well as the shared facilities and resources. All of the programs of the cancer canter are under the direction of Charles A. Coltman, Jr., M.D., cancer center Director. Currently, 96 investigators from the University Health Science Center and the Cancer Therapy and Research Center have appointments in the cancer center. These investigators participate in cancer-related research and research training projects that are supported with $12 million in grants and contracts. Development of the Institute for Cancer Research and Care/San Antonio has had a major impact on cancer research conducted at the Cancer Therapy and Research Center and the UTHSCSA, and these research programs are expected to grow significantly in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA054174-01
Application #
3101877
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1991-09-01
Project End
1994-07-31
Budget Start
1991-09-01
Budget End
1992-07-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Ctrc Research Foundation
Department
Type
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Chalela, Patricia; Muñoz, Edgar; Gallion, Kipling J et al. (2018) Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study. Transl Behav Med 8:439-449
Chalela, P; Munoz, E; Inupakutika, D et al. (2018) Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun 12:109-115
Weiner, Marc; Gelfond, Jon; Johnson-Pais, Teresa L et al. (2018) Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother 62:
Liu, Jinyou; Sareddy, Gangadhara R; Zhou, Mei et al. (2018) Differential Effects of Estrogen Receptor ? Isoforms on Glioblastoma Progression. Cancer Res 78:3176-3189
Chakravarthy, Divya; Muñoz, Amanda R; Su, Angel et al. (2018) Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett 419:103-115
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Cooney, Jeffrey D; Lin, An-Ping; Jiang, Daifeng et al. (2018) Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3K? in Mature B-cell Malignancies. Clin Cancer Res 24:1103-1113
Zhu, Haiyan; Gu, Xiang; Xia, Lu et al. (2018) A Novel TGF? Trap Blocks Chemotherapeutics-Induced TGF?1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Clin Cancer Res 24:2780-2793
Bandyopadhyay, Abhik; Favours, Edward; Phelps, Doris A et al. (2018) Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models. Pediatr Blood Cancer 65:
Azpurua, Jorge; Mahoney, Rebekah E; Eaton, Benjamin A (2018) Transcriptomics of aged Drosophila motor neurons reveals a matrix metalloproteinase that impairs motor function. Aging Cell 17:

Showing the most recent 10 out of 989 publications